Citicoline Reduces Upregulated Clusterin Following Kainic Acid Injection in the Rat Retina

REFERENCES

• Adibhatla R M, Hatcher J F. Citicoline mechanisms and clinical efficacy in cerebral ischemia. J Neurosci Res. 2002; 70: 133–139
   PubMed Web of Science ®Google Scholar
• Shuaib A, Yang Y, Li Q. Evaluating the efficacy of citicoline in embolic ischemic stroke in rats: Neuroprotective effects when used alone or in combination with urokinase. Exp Neurol. 2000; 161: 733–739
   PubMed Web of Science ®Google Scholar
• Martí Massó J F, Urtasun M. Citicoline in the treatment of Parkinson's disease. Clin Ther. 1991; 13: 239–242
   PubMedGoogle Scholar
• Mir C, Clotet J, Aledo R, Durany N, Argemí J, Lozano R, Cervós-Navarro J, Casals N. CDP-choline prevents glutamate-mediated cell death in cerebellar granule neurons. J Mol Neurosci. 2003; 20: 53–60
   PubMedGoogle Scholar
• Parisi V, Manni G, Colacino G, Bucci M G. Cytidine-5′-diphosphocholine (citicoline) improves retinal and cortical responses in patients with glaucoma. Ophthalmolog 1999; 106: 1126–1134
   PubMedGoogle Scholar
• Secades J J, Lorenzo J L. Citicoline: Pharmacological and clinical review, 2006 update. Methods Find Exp Clin Pharmacol. 2006; 28: 1–56
   PubMed Web of Science ®Google Scholar
• Wang P, Jiang Y, Huang P, Chen Z. Glutamate in experimental acute elevated intraocular pressure models of rabbits. Zhonghua Yan Ke Za Zhi. 2000; 36: 378–380
   PubMedGoogle Scholar
• Dkhissi O, Chanut E, Wasowicz M, Savoldelli M, Nguyen-Legros J, Minvielle F, Versaux-Botteri C. Retinal TUNEL-positive cells and high glutamate levels in vitreous humor of mutant quail with a glaucoma-like disorder. Invest Ophthalmol Vis Sci. 1999; 40: 990–995
   PubMed Web of Science ®Google Scholar
• Dreyer E B, Zurakowski D, Schumer R A, Podos S M, Lipton S A. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol. 1996; 114: 299–305
   PubMed Web of Science ®Google Scholar
• Perez-Navarro E, Gavalda N, Gratacos E, Alberch J. Brain-derived neurotrophic factor prevents changes in Bcl-2 family members and caspase-3 activation induced by excitotoxicity in the striatum. J Neurochem. 2005; 92: 678–691
   PubMed Web of Science ®Google Scholar
• May P C, Finch C E. Sulfated glycoprotein 2: New relationships of this multifunctional protein to neurodegeneration. Trends Neurosci. 1992; 15: 391–396
   PubMed Web of Science ®Google Scholar
• Noh H S, Kim D W, Kang S S, Cho G J, Choi W S. Ketogenic diet prevents clusterin accumulation induced by kainic acid in the hippocampus of male ICR mice. Brain Res. 2005; 42: 114–118
   Google Scholar
• Gwon J S, Kim I B, Lee M Y, Oh S J, Chun M H. Expression of clusterin in Muller cells of the rat retina after pressure-induced ischemia. Glia. 2004; 47: 35–45
   PubMedGoogle Scholar
• Jomary C, Darrow R M, Wong P, Organisciak D T, Neal M J, Jones S E. Lack of causal relationship between clusterin expression and photoreceptor apoptosis in light-induced retinal degeneration. J Neurochem. 1999; 72: 1923–1929
   PubMed Web of Science ®Google Scholar
• Hollyfield J G, Salomon R G, Crabb J W. Proteomic approaches to understanding age-related macular degeneration. Adv Exp Med Biol. 2003; 533: 83–89
   PubMed Web of Science ®Google Scholar
• Wong P, Ulyanova T, Organisciak D T, Bennett S, Lakins J, Arnold J M, Kutty R K, Tenniswood M, vanVeen T, Darrow R M, Chader G. Expression of multiple forms of clusterin during light-induced retinal degeneration. Curr Eye Res. 2001; 23: 157–165
   PubMed Web of Science ®Google Scholar
• DeMattos R B, O'dell M A, Parsadanian M, Taylor J W, Harmony J A, Bales K R, Paul S M, Holtzman D M. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA. 2002; 99: 10843–10848
   PubMed Web of Science ®Google Scholar
• Park C H, Kim Y S, Noh H S, Cheon E W, Yang Y A, Yoo J M, Choi W S, Cho G J. Neuroprotective effect of citicoline against KA-induced neurotoxicity in the rat retina. Exp Eye Res. 2005; 81: 350–358
   PubMedGoogle Scholar
• Morgan I G, Ingham C A. Kainic acid affects both plexiform layers of chicken retina. Neurosci Lett. 1981; 21: 275–280
   PubMed Web of Science ®Google Scholar
• Berger S J, McDaniel M L, Carter J G, Lowry O H. Distribution of four potential transmitter amino acids in monkey retina. J Neurochem. 1977; 28: 159–163
   PubMedGoogle Scholar
• Goto M, Inomata N, Ono H, Saito K I, Fukuda H. Changes of electroretinogram and neurochemical aspects of GABAergic neurons of retina after intraocular injection of kainic acid in rats. Brain Res. 1981; 211: 305–314
   PubMedGoogle Scholar
• Chidlow G, Osborne N N. Rat retinal ganglion cell loss caused by kainate, NMDA and ischemia correlates with a reduction in mRNA and protein of Thy-1 and neurofilament light. Brain Res. 2003; 963: 298–306
   PubMed Web of Science ®Google Scholar
• Brandstatter J H, Hartveit E, Sassoe-Pognetto M, Wassle H. Expression of NMDA and high-affinity kainate receptor subunit mRNAs in the adult rat retina. Eur J Neurosci. 1994; 6: 1100–1112
   PubMedGoogle Scholar
• Schwarcz R, Coyle J T. Kainic acid: Neurotoxic effects after intraocular injection. Invest Ophthalmol Vis Sci. 1977; 16: 141–148
   PubMed Web of Science ®Google Scholar
• Djebaili M, De Bock F., Baille V, Bockaert J, Rondouin G. Implication of p53 and caspase-3 in kainic acid but not in N-methyl-D-aspartic acid-induced apoptosis in organotypic hippocampal mouse cultures. Neurosci Lett. 2002; 327: 1–4
   PubMed Web of Science ®Google Scholar
• Chen Z, Duan R S, Quezada H C, Mix E, Nennesmo I, Adem A, Winblad B, Zhu J. Increased microglial activation and astrogliosis after intranasal administration of kainic acid in C57BL/6 mice. J Neurobiol. 2005; 62: 207–218
   PubMedGoogle Scholar
• Leskov K S, Klokov D Y, Li J, Kinsella T J, Boothman D A. Synthesis and functional analyses of nuclear clusterin, a cell death protein. J Biol Chem. 2003; 278: 11590–11600
   PubMed Web of Science ®Google Scholar
• Gleave M E, Miyake H, Zellweger T, Chi K, July L, Nelson C, Rennie P. Use of antisense oligonucleotides targeting the antiapoptotic gene, clusterin/testosterone-repressed prostate message 2, to enhance androgen sensitivity and chemosensitivity in prostate cancer. Urology. 2001; 58: 39–49
   PubMed Web of Science ®Google Scholar
• Han B H, DeMattos R B, Dugan L L, Kim-Han J S, Brendza R P, Fryer J D, Kierson M, Cirrito J, Aronow B J, Holtzman D M. Clusterin contributes to caspase-3-independent brain injury following neonatal hypoxia-ischemia. Nat Med. 2001; 7: 338–343
   PubMedGoogle Scholar
• May P C, Lampert-Etchells M, Johnson S A, Poirier J, Masters J N, Finch C E. Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat. Neuron. 1990; 5: 831–839
   PubMed Web of Science ®Google Scholar
• Jomary C, Murphy B F, Neal M J, Jones S E. Abnormal distribution of retinal clusterin in retinitis pigmentosa. Brain Res Mol Brain Res. 1993; 20: 274–278
   PubMedGoogle Scholar
• Kim Y S, Kim Y H, Cheon E W, Park J M, Yoo J M, Kang S S, Cho G J, Choi W S. Retinal expression of clusterin in the streptozotocin-induced diabetic rat. Brain Res. 2003; 976: 53–59
   PubMedGoogle Scholar
• Connor J, Buttyan R, Olsson C A, D'Agati V, O'Toole K, Sawczuk I S. SGP-2 expression as a genetic marker of progressive cellular pathology in experimental hydronephrosis. Kidney Int. 1991; 39: 1098–1103
   PubMed Web of Science ®Google Scholar
• Danik M, Chabot J G, Hassan-Gonzalez D, Suh M, Quirion R. Localization of sulfated glycoprotein-2/clusterin mRNA in the rat brain by in situ hybridization. J Comp Neurol 1993; 334: 209–227
   PubMedGoogle Scholar
• Duguid J R, Bohmount C W, Liu N G, Tourtellotte W W. Changes in brain gene expression shared by scrapie and Alzheimer disease. Proc Natl Acad Sci. 1989; 86: 7260–7264
   PubMed Web of Science ®Google Scholar
• Shannan B, Seifert M, Leskov K, Willis J, Boothman D, Tilgen W, Reichrath J. Challenge and promise: Role for clusterin in pathogenesis, progression and therapy of cancer. Cell Death and Differentiation. 2006; 13: 12–19
   PubMed Web of Science ®Google Scholar
• Choi D W. Ischemia-induced neuronal apoptosis. Curr Opin Neurobiol. 1996; 6: 667–672
   PubMed Web of Science ®Google Scholar
• Layton M E, Pazdernik T L. Reactive oxidant species in piriform cortex extracellular fluid during seizures induced by systemic kainic acid in rats. J Mol Neurosci. 1999; 13: 63–68
   PubMed Web of Science ®Google Scholar
• Noh H S, Hah Y S, Nilufar R, Han J, Bong J H, Kang S S, Cho G J, Choi W S. Acetoacetate protects neuronal cells from oxidative glutamate toxicity. J Neurosci Res. 2006; 83: 702–709
   PubMed Web of Science ®Google Scholar
• Fresta M, Puglisi G, Di Giacomo C, Russo A. Liposomes as in-vivo carriers for citicoline: Effects on rat cerebral post-ischaemic reperfusion. J Pharm Pharmacol. 1994; 46: 974–981
   PubMed Web of Science ®Google Scholar
• Adibhatla R M, Hatcher J F, Dempsey R J. Phospholipase A2, hydroxyl radicals, and lipid peroxidation in transient cerebral ischemia. Antioxid Redox Signal. 2003; 5: 647–654
   PubMed Web of Science ®Google Scholar
• Adibhatla R M, Hatcher J F. Citicoline decreases phospholipase A2 stimulation and hydroxyl radical generation in transient cerebral ischemia. J Neurosci Res. 2003; 73: 308–315
   PubMed Web of Science ®Google Scholar
• D'Orlana K J, Sandage B W, Jr. Citicoline (CDP-choline): Mechanisms of action and effects in ischemic brain injury. Neurol Res. 1995; 17: 281–284
   PubMedGoogle Scholar
• Adibhatla R M, Hatcher J F, Dempsey R J. Citicoline: Neuroprotective mechanisms in cerebral ischemia. J Neurochem 2002; 80: 12–23
   PubMed Web of Science ®Google Scholar
• Adibhatla R M, Hatcher J F, Larsen E C, Chen X, Sun D, Tsao F H. CDP-choline significantly restores phosphatidylcholine levels by differentially affecting phospholipase A2 and CTP: Phosphocholine cytidylyltransferase after stroke. J Biol Chem 2006; 281: 6718–6725
   PubMed Web of Science ®Google Scholar
• Schuettauf F, Rejdak R, Thaler S, Bolz S, Lehaci C, Mankowska A, Zarnowski T, Junemann A, Zagorski Z, Zrenner E, Grieb P. Citicoline and lithium rescue retinal ganglion cells following partial optic nerve crush in the rat. Exp Eye Res 2006; 83: 1128–1134
   PubMed Web of Science ®Google Scholar
• Sobrado M, López M G, Carceller F, García A G, Roda J M. Combined nimodipine and citicoline reduce infarct size, attenuate apoptosis and increase bcl-2 expression after focal cerebral ischemia. Neuroscience. 2003; 118: 107–113
   PubMed Web of Science ®Google Scholar
• Barrachina M, Secades J, Lozano R, Gómez-Santos C, Ambrosio S, Ferrer I. Citicoline increases glutathione redox ratio and reduces caspase-3 activation and cell death in staurosporine-treated SH-SY5Y human neuroblastoma cells. Brain Res 2002; 957: 84–90
   PubMedGoogle Scholar
• Krupinski J, Ferrer I, Barrachina M, Secades J J, Mercadal J, Lozano R. CDP-choline reduces pro-caspase and cleaved caspase-3 expression, nuclear DNA fragmentation, and specific PARP-cleaved products of caspase activation following middle cerebral artery occlusion in the rat. Neuropharmacology. 2002; 42: 846–854
   PubMed Web of Science ®Google Scholar
• Hurtado O, Moro M A, Cárdenas A, Sánchez V, Fernández-Tomé P, Leza J C, Lorenzo P, Secades J J, Lozano R, Dávalos A, Castillo J, Lizasoain I. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: Effects on glutamate transport. Neurobiol Dis. 2005; 18: 336–345
   PubMed Web of Science ®Google Scholar